Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 19.269% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] COc1ccc(OC)c(NC(=O)C(CCS(C)(=O)=O)NC(C)=O)c1
[b] CCC(=O)Nc1nnc(-c2ccncc2)s1
[c] CCCCn1c(N)c(C(=O)NCc2cccs2)c2nc3ccccc3nc21
Answer: b. CCC(=O)Nc1nnc(-c2ccncc2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1nnc(-c2ccncc2)s1
CCC(=O)Nc1nnc(-c2ccncc2)s1
N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)propanamide